MRUS
Asset Logo

Merus NV

🇺🇸 NYSE/NASDAQ

📈 HIGH PRICE GROWTH

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 37.32%
Annual Growth

5 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States.

📈 Performance

Price History*

+326.22%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$42.93

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in MRUS

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

20 weeks

💵 Average investment amount

$1,968

Last time a customer invested in MRUS

107 days
MRUS investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100%

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

100%
🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in MRUS also invest in...

C4 Therapeutics, Inc

CCCC

📊 Share price

$4.05 USD
Find Out More

🙌 Performance (5Yr p.a)

-12.40%

📊 Share price

$3.28 USD

🙌 Performance (5Yr p.a)

-6.11%

📊 Share price

$2.23 USD

📊 Share price

$12.73 USD

🙌 Performance (5Yr p.a)

1.45%

📊 Share price

$94.01 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

5.39%

📊 Share price

$16.59 USD
Compare
Add to watchlist